Recurrent pregnancy loss: the key potential mechanisms

Laird, 2003, A review of immune cells and molecules in women with recurrent miscarriage, Hum. Reprod. Update, 9, 163, 10.1093/humupd/dmg013 Hogge, 2003, The clinical use of karyotyping spontaneous abortions, Am. J. Obstet. Gynecol., 189, 397, 10.1067/S0002-9378(03)00700-2 Regan, 1989, Influence of past reproductive performance on risk of spontaneous abortion, BMJ, 299, 541, 10.1136/bmj.299.6698.541 Baek, 2004, Aberrant gene expression associated with recurrent pregnancy loss, Mol. Hum. Reprod., 10, 291, 10.1093/molehr/gah049 Pandey, 2005, An update in recurrent spontaneous abortion, Arch. Gynecol. Obstet., 272, 95, 10.1007/s00404-004-0706-y Rai, 2006, Recurrent miscarriage, Lancet, 368, 601, 10.1016/S0140-6736(06)69204-0 Christiansen, 2005, Evidence-based investigations and treatments of recurrent pregnancy loss, Fertil. Steril., 83, 821, 10.1016/j.fertnstert.2004.12.018 Baek, 2002, The comparison of gene expression at the feto-maternal interface between normal and recurrent pregnancy loss patients, Reprod. Fertil. Dev., 14, 235, 10.1071/RD02008 Choi, 2003, The expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients, Mol. Reprod. Dev., 66, 24, 10.1002/mrd.10331 Lee, 2005, Trophoblast apoptosis is increased in women with evidence of Th-1 immunity, Fertil. Steril., 83, 1047, 10.1016/j.fertnstert.2004.07.979 Kim, 2006, Proteomic analysis of recurrent spontaneous abortion: identification of an inadequately expressed set of proteins in human follicular fluid, Proteomics, 6, 3445, 10.1002/pmic.200500775 Oliver-Minarro, D. et al. Isolated type 5 antimitochondrial autoantibodies are associated with a history of thrombocytopenia and fetal loss. Fertil. Steril. (in press) Girardi, 2004, Heparin prevents antiphospholipid antibody induced fetal loss by inhibiting complement activation, Nat. Med., 10, 1222, 10.1038/nm1121 Simmelink, 2001, Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces, Br. J. Haematol., 113, 621, 10.1046/j.1365-2141.2001.02755.x Patterson, 2006, The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells, Br. J. Haematol., 133, 323, 10.1111/j.1365-2141.2006.05994.x Noble, 2005, Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin, Fertil. Steril., 83, 684, 10.1016/j.fertnstert.2004.11.002 Hviid, 2006, HLA-G in human reproduction: aspects of genetics, function and pregnancy complications, Hum. Reprod. Update, 12, 209, 10.1093/humupd/dmi048 Kwak-Kim, 2003, A Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF, Hum. Reprod., 18, 767, 10.1093/humrep/deg156 Zenclussen, 2002, Questioning the Th1/Th2 paradigm in reproduction: peripheral levels of IL-12 are down-regulated in miscarriage patients, Am. J. Reprod. Immunol., 48, 245, 10.1034/j.1600-0897.2002.01136.x Ain, 2003, Gestation stage-dependent intrauterine trophoblast cell invasion in the rat and mouse: novel endocrine phenotype and regulation, Dev. Biol., 260, 176, 10.1016/S0012-1606(03)00210-0 Taylor, 2006, Pregnancy-linked suppression of TcR signaling pathways by a circulating factor absent in recurrent spontaneous pregnancy loss (RPL), Mol. Immunol., 43, 1872, 10.1016/j.molimm.2005.10.008 Fukui, 2006, Expression of natural cytotoxicity receptors and a2V-ATPase on peripheral blood NK cell subsets in women with recurrent spontaneous abortions and implantation failures, Am. J. Reprod. Immunol., 56, 312, 10.1111/j.1600-0897.2006.00431.x Lambropoulou, 2006, Imbalance of mononuclear cell infiltrates in the placental tissue from foetuses after spontaneous abortion versus therapeutic termination from 8th to 12th weeks of gestational age, Clin. Exp. Med., 6, 171, 10.1007/s10238-006-0111-x Arruvito, 2007, Expansion of CD4+CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction, J. Immunol., 178, 2572, 10.4049/jimmunol.178.4.2572 Mukhopadhyay, 2004, Glycodelin A, not glycodelin S, is apoptotically active. Relevance of sialic acid modification, J. Biol. Chem., 279, 8577, 10.1074/jbc.M306673200 Angelucci, 2006, Proteome analysis of human follicular fluid, Biochim. Biophys. Acta, 1764, 1775, 10.1016/j.bbapap.2006.09.001 Schmidt, 2000, Complement: a critical test of its biological importance, Immunol. Rev., 178, 166, 10.1034/j.1600-065X.2000.17801.x Girardi, 2006, The complement system in the pathophysiology of pregnancy, Mol. Immunol., 43, 68, 10.1016/j.molimm.2005.06.017 Bulla, 2005, The complement system at the fetomaternal interface, Chem. Immunol. Allergy, 89, 149, 10.1159/000087963 Holers, 2002, Complement C3 activation is required for the antiphospholipid antibody-induced fetal loss, J. Exp. Med., 195, 211, 10.1084/jem.200116116 Molina, 2005, Complement regulation during pregnancy, Immunol. Res., 32, 187, 10.1385/IR:32:1-3:187 Sugiura-Ogasawara, 2006, Complement as a predictor of further miscarriage in couples with recurrent miscarriages, Hum. Reprod., 21, 2711, 10.1093/humrep/del229 Omwandho, 2000, Recurrent pregnancy losses and the role of immunotherapy, Arch. Gynecol. Obstet., 264, 3, 10.1007/PL00007480 Nguyen, 2006, Renin/prorenin receptors, Kidney Int., 69, 1503, 10.1038/sj.ki.5000265 Harata, 2006, Localization of angiotensin II, the AT1 receptor, angiotensin-converting enzyme, aminopeptidase A, adipocyte-derived leucine aminopeptidase, and vascular endothelial growth factor in the human ovary throughout the menstrual cycle, Fertil. Steril., 86, 433, 10.1016/j.fertnstert.2006.01.041 Tempfer, 2000, Genetic control of fertility and embryonic waste in the mouse: a role for angiotensinogen, Biol. Reprod., 62, 457, 10.1095/biolreprod62.2.457 Lizanecz, 2006, Mistyping of angiotensinogen M235T alleles, Hypertens. Res., 29, 197, 10.1291/hypres.29.197 Bouba, 2003, Interaction between the polymorphisms of the renin-angiotensin system in preeclampsia, Eur. J. Obstet. Gynecol. Reprod. Biol., 110, 8, 10.1016/S0301-2115(03)00046-0 Collen, 2001, Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aα-chain, alters endothelial capillary tube formation, Blood, 97, 973, 10.1182/blood.V97.4.973 Kovar, F.M. et al. The fibrinogen -148 C/T polymorphism influences inflammatory response in experimental endotoxemia in vivo. Thromb. Res. (in press) de Willige, S.U. et al. Polymorphism 10034C> T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen gamma’/gammaA mRNA ratio. J. Thromb. Haemost. (in press) Kathiresan, 2006, Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk, Arterioscler. Thromb. Vasc. Biol., 26, 1405, 10.1161/01.ATV.0000222011.13026.25 Bick, 2005, Recurrent miscarriage syndrome and infertility due to blood coagulation protein/platelet defects: a review and update, Clin. Appl. Thromb. Hemost., 11, 1, 10.1177/107602960501100101 Anwar, 1999, Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity, Blood, 93, 897, 10.1182/blood.V93.3.897 Lockwood, 2002, Inherited thrombophilias in pregnant patients: detection and treatment paradigm, Obstet. Gynecol., 99, 333, 10.1016/S0029-7844(01)01760-4 Franchini, 2006, Haemostasis and pregnancy, Thromb. Haemost., 95, 401, 10.1160/TH05-11-0753 Ishiguro, 2000, Complete antithrombin deficiency in mice results in embryonic lethality, J. Clin. Invest., 106, 873, 10.1172/JCI10489 Mosesson, 2005, Fibrinogen and fibrin structure and functions, J. Thromb. Haemost., 3, 1894, 10.1111/j.1538-7836.2005.01365.x Martinelli, 2000, Mutations in coagulation factors in women with unexplained late fetal loss, N. Engl. J. Med., 343, 1015, 10.1056/NEJM200010053431405 Preston, 1996, Increased fetal loss in women with heritable thrombophilia, Lancet, 348, 913, 10.1016/S0140-6736(96)04125-6 Brenner, 1996, Coexistence of familial antiphospholipid syndrome and factor V Leiden: impact on thrombotic diathesis, Br. J. Haematol., 94, 166, 10.1046/j.1365-2141.1996.d01-1757.x Younis, 2000, Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second trimester recurrent pregnancy loss, Am. J. Reprod. Immunol., 43, 31, 10.1111/j.8755-8920.2000.430106.x Rai, 2001, Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage, Hum. Reprod., 16, 961, 10.1093/humrep/16.5.961 Bare, 2000, Factor V Leiden as a risk factor for miscarriage and reduced fertility, Aust. N. Z. J. Obstet. Gynaecol., 40, 186, 10.1111/j.1479-828X.2000.tb01144.x Kutteh, 1999, Hypercoagulable state mutation analysis in white patients with early firsttrimester recurrent pregnancy loss, Fertil. Steril., 71, 1048, 10.1016/S0015-0282(99)00133-8 Rey, 2003, Thrombophilic disorders and fetal loss: a meta-analysis, Lancet, 361, 901, 10.1016/S0140-6736(03)12771-7 Lijnen, 2005, Pleiotropic functions of plasminogen activator inhibitor-1, J. Thromb. Haemost., 3, 35, 10.1111/j.1538-7836.2004.00827.x Latacha, 2004, Factor XII-dependent increases in thrombin activity induce carboxypeptidase-mediated attenuation of pharmacological fibrinolysis, J. Thromb. Haemost., 2, 128, 10.1111/j.1538-7836.2004.00538.x Kleinschnitz, 2006, Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis, J. Exp. Med., 203, 513, 10.1084/jem.20052458 Dunn, 2005, Type 2 diabetes: an atherothrombotic syndrome, Curr. Mol. Med., 5, 323, 10.2174/1566524053766059 Glueck, 2000, The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications, Metabolism, 49, 845, 10.1053/meta.2000.6749 Buchholz, 2003, Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages, Hum. Reprod., 18, 2473, 10.1093/humrep/deg474 Ogasawara, 2001, Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage, Fertil. Steril., 75, 916, 10.1016/S0015-0282(01)01688-0 Yamada, 2000, FXII deficiency in women with recurrent miscarriage, Gynecol. Obstet. Invest., 49, 80, 10.1159/000010220 Matsuura, 2001, Is factor XII deficiency related to recurrent miscarriage?, Semin. Thromb. Hemost., 27, 115, 10.1055/s-2001-14069 Empson, 2005, Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant, Cochrane Database Syst. Rev., 2, 10.1002/14651858.CD002859.pub2 Huppertz, 2006, Apoptosis and its role in the trophoblast, Am. J. Obstet. Gynecol., 195, 29, 10.1016/j.ajog.2005.07.039 Qiu, 2005, Fas ligand expression by maternal decidual cells is negatively correlated with the abundance of leukocytes present at the maternal-fetal interface, J. Reprod. Immunol., 65, 121, 10.1016/j.jri.2005.01.007 Liu, 2003, Effect of IFNγ on caspase-3, Bcl-2 and Bax expression, and apoptosis in rabbit placenta, Cytokine, 24, 201, 10.1016/j.cyto.2003.09.002 Reynolds, 2001, Angiogenesis in the placenta, Biol. Reprod., 64, 1033, 10.1095/biolreprod64.4.1033 Charnock-Jones, 2004, Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation, Placenta, 25, 103, 10.1016/j.placenta.2003.10.004